Form D · Other Health Care
NEPHROS INC
South Orange, NJ · CIK 0001196298
Offering snapshot reported Sep 7, 2021 · SEC filing
- Reported sold
- $2.1M Offering amount: $2.44M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 7, 2021 | Amendment | $2,102,615 | No comparison | Not reported | SEC filing |
| Jul 14, 2021 | Initial | $1,200,000 | No comparison | Not reported | SEC filing |
| Sep 4, 2020 | Amendment | $1,998,000 | $570,000vs Sep 18, 2018 | 19 | SEC filing |
| Sep 12, 2019 | Amendment | $1,504,000 | $76,000vs Sep 18, 2018 | 19 | SEC filing |
| May 21, 2019 | Initial | $2,000,000 | No comparison | 12 | SEC filing |
| Sep 18, 2018 | Amendment | $1,265,000 | No comparison | 1 | SEC filing |
| Sep 18, 2018 | Amendment | $1,428,000 | No comparison | 19 | SEC filing |
| Apr 18, 2018 | Initial | $2,943,301 | No comparison | 13 | SEC filing |
| Aug 11, 2017 | Amendment | $297,500 | $0vs Aug 1, 2016 | 1 | SEC filing |
| Mar 27, 2017 | Initial | $2,436,000 | No comparison | 19 | SEC filing |
| Aug 1, 2016 | Amendment | $297,500 | $135,000vs Aug 5, 2015 | 1 | SEC filing |
| Aug 5, 2015 | Initial | $162,500 | No comparison | 1 | SEC filing |
| Aug 7, 2009 | Initial | $1,251,000 | No comparison | 8 | SEC filing |
| Oct 4, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-283400
Source: Form D, filed Sep 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arthur Amron | Director |
| Andrew Astor | Director, Executive |
| Lawrence Centella | Director |
| Ermest A. Elgin, Iii | Executive |
| Daron Evans | Director, Executive |
| Thomas Gwydir | Director |
| Gerald J. Kochanski | Executive |
| Alisa Lask | Director |
| Paul Mieyal | Director |
| Dr. Paul A. Mieyal | Director |
| Malcolm Persen | Director |
| Malcolm Person | Director |
| Moshe Pinto | Director |
| Matthew Rosenberg | Director |
| James S. Scibetta | Director |
| Oliver Spandow | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
380 Lackawanna Place
South Orange, NJ, 07079
South Orange, NJ, 07079